TherageniX delivers genes that direct the body to make necessary proteins or substances that aid in tissue regeneration.
TherageniX has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in August 2023.
TherageniX's investors include Innovate UK.
TherageniX is headquartered in London, United Kingdom.
TherageniX delivers genes that direct the body to make necessary proteins or substances that aid in tissue regeneration.
TherageniX is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TherageniX — Funding & Investors." VCBacked, August 31, 2023, https://www.vcbacked.co/company/theragenix. Accessed November 13, 2026.
VCBacked. (2023). TherageniX — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/theragenix
{{cite web |title=TherageniX — Funding & Investors |url=https://www.vcbacked.co/company/theragenix |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at TherageniX? Request a listing update